Rainbow Childrens Medicare · NSE: RAINBOW · BSE: 543524
Q3 FY25 results · Oct–Dec 2024
Rainbow Childrens Medicare reported revenue from operations of ₹398.08 crore (up 18.5% from Q3 FY24) and net profit of ₹68.94 crore (up 10.2% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 398.08 | 335.96 | +18.5% | 417.46 | −4.6% |
| Other income | 13.27 | 8.61 | +54.2% | 11.27 | +17.8% |
| Total income | 411.36 | 344.57 | +19.4% | 428.73 | −4.1% |
| Profit before tax | 94.33 | 84.77 | +11.3% | 105.35 | −10.5% |
| Net profit for the period | 68.94 | 62.57 | +10.2% | 79.00 | −12.7% |
| Attributable to shareholders of the company | 68.69 | 62.12 | +10.6% | 78.87 | −12.9% |
| EPS, basic (₹) | 6.76 | 6.12 | +10.5% | 7.77 | −13.0% |
| Net margin (%) | 17.3 | 18.6 | 18.9 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 381.56 | 321.79 | +18.6% | 403.93 | −5.5% |
| Other income | 12.85 | 8.24 | +55.9% | 10.72 | +19.8% |
| Total income | 394.41 | 330.03 | +19.5% | 414.65 | −4.9% |
| Profit before tax | 92.11 | 82.55 | +11.6% | 103.60 | −11.1% |
| Net profit for the period | 66.97 | 61.14 | +9.5% | 77.34 | −13.4% |
| EPS, basic (₹) | 6.60 | 6.03 | +9.5% | 7.62 | −13.4% |
| Net margin (%) | 17.6 | 19.0 | 19.1 |
Consolidated
- Filed with BSE
- 10 Feb 2025, 13:11 IST
- Board meeting
- 09 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Feb 2025, 13:11 IST
- Board meeting
- 09 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE